American College of Cardiology
Avatar

FIGARO-DKD Trial: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes

By American College of Cardiology FEATURING Valentin Fuster, Dipti Itchhaporia, Michael Mack, Christine Albert, Julia Grapsa
By American College of Cardiology FEATURING Valentin Fuster, Dipti Itchhaporia, Michael Mack, Christine Albert, Julia Grapsa
216 views
February 15, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
47:11
Houston Methodist Hospital

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis
12:04
Stephen Kopecky

Role of PCSK9 Inhibitors in Diabetes

49:21
Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key
28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason
23:35
Practical Ways to Achieve Targets in Diabetes Care

Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)

Feat. I. Hirsch
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

17:22
Samuel Sherratt

Sotagliflozin, a Dual SGLT 1 and 2 Inhibitor, Has High Membrane Affi…

26:32
Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen
26:49
Diana Isaacs

Tirzepatide Updates

44:43
Jason Fung

Type 2 Diabetes Aetiology and Reversibility

33:23
Keck School of Medicine of USC

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Feat. M. Goran
19:20
National Lipid Association

Colchicine: Now and What’s Next?

Feat. C. Ballantyne
22:14
Practical Ways to Achieve Targets in Diabetes Care

Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target

Feat. S. Nissen
21:10
National Lipid Association

Plant-based Diets for Improving Lipids

Feat. K. Williams
10:02
Emory Diabetes Education Training Academy

Insulin Treatment in Patients with Type 2 Diabetes: When to Use Comb…

Feat. G. Umpierrez